Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 9, Pages 2059
Publisher
MDPI AG
Online
2022-04-20
DOI
10.3390/cancers14092059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Negative Feedback Loop Between NAMPT and TGF-β Signaling Pathway in Colorectal Cancer Cells
- (2021) Xiaoqun Lv et al. OncoTargets and Therapy
- MiR-613 Promotes Cell Death in Breast Cancer Cells by Downregulation of Nicotinamide Phosphoribosyltransferase and Reduction of NAD
- (2021) Shahin Alizadeh-Fanalou et al. DNA AND CELL BIOLOGY
- Optical Redox Imaging of Treatment Responses to Nampt Inhibition and Combination Therapy in Triple-Negative Breast Cancer Cells
- (2021) Allison Podsednik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level
- (2020) Chenyang Ye et al. Cell Communication and Signaling
- Pan-cancer analysis of whole genomes
- (2020) NATURE
- Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)
- (2020) Monika Pazgan-Simon et al. PLoS One
- Single-Cell RNA Sequencing of a Postmenopausal Normal Breast Tissue Identifies Multiple Cell Types That Contribute to Breast Cancer
- (2020) Sen Peng et al. Cancers
- NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma
- (2020) Valentina Audrito et al. Cancers
- NAMPT and NAPRT, Key Enzymes in NAD Salvage Synthesis Pathway, Are of Negative Prognostic Value in Colorectal Cancer
- (2019) Xiao-qin Li et al. Frontiers in Oncology
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
- (2018) Charissa Kim et al. CELL
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- NAD + Intermediates: The Biology and Therapeutic Potential of NMN and NR
- (2018) Jun Yoshino et al. Cell Metabolism
- Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
- (2018) Mickaël Ohanna et al. GENES & DEVELOPMENT
- Expression of NAMPT is associated with breast invasive ductal carcinoma development and prognosis
- (2018) Shao‑Jie Zhou et al. Oncology Letters
- NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils
- (2018) Ekaterina Pylaeva et al. INTERNATIONAL JOURNAL OF CANCER
- Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer
- (2018) Jing-hua Pan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Increased Nicotinamide adenine dinucleotide pool promotes colon cancer progression by suppressing reactive oxygen species level
- (2018) Sun M. Hong et al. CANCER SCIENCE
- Circulating visfatin levels and cancers risk: A systematic review and meta-analysis
- (2018) Masoumeh Mohammadi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- NAD metabolism fuels human and mouse intestinal inflammation
- (2017) Romana R Gerner et al. GUT
- Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
- (2017) Valentina Audrito et al. JNCI-Journal of the National Cancer Institute
- Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells
- (2017) Zafar Gholinejad et al. PEPTIDES
- Chemotherapy and plasma adipokines level in patients with colorectal cancer
- (2017) Grzegorz Słomian et al. Postepy Higieny I Medycyny Doswiadczalnej
- A subcellular map of the human proteome
- (2017) Peter J. Thul et al. SCIENCE
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma
- (2017) Xin Yue Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer
- (2017) Ruli Gao et al. Nature Communications
- Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
- (2017) Woosung Chung et al. Nature Communications
- Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
- (2017) Yifan Sun et al. Oncotarget
- Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
- (2017) Valentina Audrito et al. JNCI-Journal of the National Cancer Institute
- Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases
- (2016) Guanghai Wang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Small interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) induce growth inhibition and apoptosis in human multiple myeloma cells: A preliminary study
- (2016) Ivyna Bong Pau Ni et al. Bosnian Journal of Basic Medical Sciences
- Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer
- (2016) Huai-Qiang Ju et al. CANCER LETTERS
- Extracellular Visfatin-Promoted Malignant Behavior in Breast Cancer Is Mediated Through c-Abl and STAT3 Activation
- (2016) A. C. Hung et al. CLINICAL CANCER RESEARCH
- Visfatin triggers the in vitro migration of osteosarcoma cells via activation of NF-κB/IL-6 signals
- (2016) Guang-Ji Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways
- (2016) Yingmei Wang et al. GYNECOLOGIC ONCOLOGY
- NAMPT Inhibitor GMX1778 Enhances the Efficacy of 177 Lu-DOTATATE Treatment of Neuroendocrine Tumors
- (2016) Anna-Karin Elf et al. JOURNAL OF NUCLEAR MEDICINE
- Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth
- (2016) O. Abu Aboud et al. MOLECULAR CANCER THERAPEUTICS
- Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma
- (2016) Hai-Ping Zhang et al. Oncology Letters
- Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism
- (2016) Jing Yang et al. Oncotarget
- Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway
- (2016) Jun Feng et al. Biomed Research International
- Relations of Serum Visfatin and Resistin Levels with Endometrial Cancer and Factors Associated with its Prognosis
- (2015) Tolgay Tuyan Ilhan et al. Asian Pacific Journal of Cancer Prevention
- FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells
- (2015) Susanne Schuster et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The NAD+ salvage pathway modulates cancer cell viability via p73
- (2015) T Sharif et al. CELL DEATH AND DIFFERENTIATION
- Visfatin derived from ascites promotes ovarian cancer cell migration through Rho/ROCK signaling-mediated actin polymerization
- (2015) Yan Li et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2
- (2015) Tingting Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High glucose promotes gastric cancer chemoresistance in vivo and in vitro
- (2015) WEI ZHAO et al. Molecular Medicine Reports
- Physiological and pathophysiological roles of NAMPT and NAD metabolism
- (2015) Antje Garten et al. Nature Reviews Endocrinology
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
- (2015) Nadia Sawicka-Gutaj et al. TUMOR BIOLOGY
- Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer
- (2015) Hyun-Joo Park et al. Oncotarget
- Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer
- (2014) Antonio F. Santidrian et al. DNA REPAIR
- Elevated plasma visfatin levels correlate with poor prognosis of gastric cancer patients
- (2014) Guo-Wen Lu et al. PEPTIDES
- A H2S-Nampt Dependent Energetic Circuit Is Critical to Survival and Cytoprotection from Damage in Cancer Cells
- (2014) Reiko Sanokawa-Akakura et al. PLoS One
- Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors
- (2014) Weiru Wang et al. PLoS One
- NAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples
- (2014) Sara Duarte-Pereira et al. Scientific Reports
- Intracellular NAD+ depletion enhances bortezomib-induced anti-myeloma activity
- (2013) A. Cagnetta et al. BLOOD
- NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity
- (2013) Sathisha Upparahalli Venkateshaiah et al. EXPERIMENTAL HEMATOLOGY
- Preoperative serum visfatin levels and prognosis of breast cancer among Chinese women
- (2013) Xiao-Yang Li et al. PEPTIDES
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Upregulation of thromboxane synthase mediates visfatin-induced interleukin-8 expression and angiogenic activity in endothelial cells
- (2012) Su-Ryun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: An in vitro study
- (2012) RAFAŁ JAKUB BUŁDAK et al. ONCOLOGY REPORTS
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway
- (2011) Joo-Won Park et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Possible Role of Visfatin in Hepatoma Progression and the Effects of Branched-Chain Amino Acids on Visfatin-Induced Proliferation in Human Hepatoma Cells
- (2011) S. Ninomiya et al. Cancer Prevention Research
- Notch1 mediates visfatin-induced FGF-2 up-regulation and endothelial angiogenesis
- (2010) Yun-Hee Bae et al. CARDIOVASCULAR RESEARCH
- Efficacy of Combining GMX1777 with Radiation Therapy for Human Head and Neck Carcinoma
- (2010) H. Kato et al. CLINICAL CANCER RESEARCH
- Visfatin stimulates proliferation of MCF-7 human breast cancer cells
- (2010) Jae Geun Kim et al. MOLECULES AND CELLS
- Towards a knowledge-based Human Protein Atlas
- (2010) Mathias Uhlen et al. NATURE BIOTECHNOLOGY
- PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas
- (2010) John T. Lee et al. Pigment Cell & Melanoma Research
- Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis
- (2009) Jee-Young Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Involvement of dimethylarginine dimethylaminohydrolase-2 in visfatin-enhanced angiogenic function of endothelial cells
- (2009) Jian Xiao et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The UCSC Cancer Genomics Browser
- (2009) Jingchun Zhu et al. NATURE METHODS
- Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: Role in visfatin-induced angiogenesis
- (2008) Raghu Adya et al. ATHEROSCLEROSIS
- Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients
- (2008) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started